Quest PharmaTech Inc. Share Price Other OTC
Equities
QPTFF
CA74836M1068
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 11.84M 8.68M 682M |
---|---|---|---|---|---|
Net income 2022 | -85M -62.33M -4.9B | Net income 2023 | -7M -5.13M -403M | EV / Sales 2022 | - |
Net Debt 2022 | 250K 183K 14.38M | Net Debt 2023 | 625K 459K 36.02M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.18
x | P/E ratio 2023 |
-1.61
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 82.88% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 16/06/04 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 31/12/04 |
Eliel Bayever
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 16/06/04 | |
J. Lievonen
CHM | Chairman | - | 04/07/21 |
Jeffrey Shon
BRD | Director/Board Member | - | 04/07/21 |
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |